|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1989-9-1
|
|
pubmed:abstractText |
To assess the activity of taxol in patients with advanced, progressive, and drug-refractory ovarian cancer and to delineate more clearly the toxicity of taxol in this patient population.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
111
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
273-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2569287-Alkaloids,
pubmed-meshheading:2569287-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:2569287-Arrhythmias, Cardiac,
pubmed-meshheading:2569287-Cisplatin,
pubmed-meshheading:2569287-Drug Evaluation,
pubmed-meshheading:2569287-Epilepsy, Tonic-Clonic,
pubmed-meshheading:2569287-Female,
pubmed-meshheading:2569287-Hematologic Diseases,
pubmed-meshheading:2569287-Humans,
pubmed-meshheading:2569287-Joint Diseases,
pubmed-meshheading:2569287-Muscular Diseases,
pubmed-meshheading:2569287-Ovarian Neoplasms,
pubmed-meshheading:2569287-Paclitaxel,
pubmed-meshheading:2569287-Pain,
pubmed-meshheading:2569287-Peripheral Nervous System Diseases
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
|
|
pubmed:affiliation |
Johns Hopkins Oncology Center, Baltimore, Maryland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
